{"id":"W2789480593","doi":"10.1093/jcag/gwy009.119","title":"A119 THERAPUTIC DRUG MONITORING IN PATIENTS WITH ULCERATIVE COLITIS TREATED WITH GOLIMUMAB","year":2018,"lang":"en","type":"article","venue":"Journal of the Canadian Association of Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Western University","funders":"","keywords":"Golimumab; Medicine; Ulcerative colitis; Adalimumab; Infliximab; Internal medicine; Therapeutic drug monitoring; Trough level; Etanercept; Vedolizumab; Inflammatory bowel disease; Regimen; Gastroenterology; Drug; Pharmacokinetics; Surgery; Tumor necrosis factor alpha; Pharmacology; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005235725,0.0001685595,0.0004777313,0.0008799072,0.0004585839,0.0006331134,0.0001933206,0.0003763034,0.0009738908],"category_scores_gemma":[0.001571823,0.000167195,0.000460167,0.001200974,0.0001890971,0.0004844118,0.0003143477,0.000624298,0.0002319043],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002853925,"about_ca_system_score_gemma":0.0003228555,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001141508,"about_ca_topic_score_gemma":0.00123571,"domain_scores_codex":[0.9993681,0.0001620733,0.000138364,0.00009903376,0.0001412032,0.0000912945],"domain_scores_gemma":[0.9987325,0.0002078641,0.0007196745,0.00005251989,0.0001327152,0.0001546423],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002725125,0.00005458105,0.9932014,0.00003635768,0.00002935382,0.0004343945,0.00007144815,0.00002427086,0.0002789987,0.0000120978,0.0001273435,0.005457195],"study_design_scores_gemma":[0.00002051465,0.0004639905,0.9949084,0.00003762492,0.00005823051,0.002870372,0.0001948069,0.0001880078,0.0002212926,0.00002488663,0.001006251,0.000005508263],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.995549,0.002815956,0.0001424523,0.0001330411,0.00001161735,0.00002038743,0.0002214374,0.000008372395,0.00109775],"genre_scores_gemma":[0.9988017,0.000520494,0.0001986259,0.00009502813,0.00001993905,0.00001124082,0.0002321986,0.00000205485,0.0001188475],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001141508,"threshold_uncertainty_score":0.00325793,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.002834887187064636,"score_gpt":0.190070738239866,"score_spread":0.1872358510528014,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}